| Ytd | -94.79% | |
| 1y | -47.32% |
| Open | 1.47 | Prev Close | 1.47 | Low | 1.47 | High | 1.47 | Mkt Cap | 39.14M |
| Vol | 86.83K | Avg Vol | 552.07K | EPS | -28.50 | P/E | -0.05 | Forward P/E | -0.63 |
| Beta | 0.26 | Short Ratio | 0.07 | Inst. Own | 2.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 3.53 | 200-d Avg | 9.62 | 1yr Est | 3.73 |
NBY News
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) announced Monday its corporate name change to Stablecoin D
Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de
KALA BIO shares jumped over 22% after Oxford Finance acquired a 16.5% stake, amid recent leadership
KALA BIO shares surged over 37% in after-hours trading following a private placement, loan settlemen
EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American:
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quart
On Monday, 429 stocks made new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.